BRCAness, SLFN11, and RB1 loss predict response to...

Science Translational Medicine 2020 / 02 Vol. 12; Iss. 531

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Coussy, Florence, El-Botty, Rania, Château-Joubert, Sophie, Dahmani, Ahmed, Montaudon, Elodie, Leboucher, Sophie, Morisset, Ludivine, Painsec, Pierre, Sourd, Laura, Huguet, Léa, Nemati, Fariba, Serv
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.aax2625
Date:
February, 2020
File:
PDF, 10.56 MB
english, 2020
Conversion to is in progress
Conversion to is failed